Nuvation Bio (NUVB) has quietly turned into one of the market’s stronger biotech movers, with the stock up about 78% over the past month and more than tripling year to date. See our latest analysis ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generation Bio, which once ...

The price band for the Neochem Bio IPO has been set between ₹93 and ₹98 per equity share. The basis of allotment for the Neochem Bio IPO is expected to be finalised on Friday, December 5. Successful ...

The commercial supply of bio-CNG, or Compressed Biogas, produced at the Arail plant in Naini here commenced on Monday. Mayor Umesh Chandra Ganesh Kesarwani showed the green flag to CNG vehicles at the ...

Cabaletta Bio (CABA) drew fresh attention from investors after announcing encouraging clinical trial results for rese-cel in several autoimmune diseases. Presentations at the American College of ...

Add Yahoo as a preferred source to see more of our stories on Google. [Image Credit: BIO IONIC] A nationwide Bio Ionic curling iron recall has been issued due to the product causing multiple burn ...

SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- NSG Bio, a leading provider of flexible and high-quality biotech laboratory spaces, announced the launch of its latest product, NSG BioSuites, located at the ...

Gwyneth Paltrow is ready to talk about "Gwyneth." The Oscar winner told British Vogue in an interview that she has yet to read the biography, released in July by culture and fashion journalist Amy ...

Can a 3D Minecraft implementation be done entirely in CSS and HTML, without a single line of JavaScript in sight? The answer is yes! True, this small clone is limited to playing with blocks in a world ...

Think of your Tinder bio as your dating app elevator pitch—a quick and dirty explanation of who you are and what your vibe is. In an era where dating burnout is high and meeting someone compatible isn ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million. Bluebird makes three gene therapies: Zynteglo for beta thalassemia, Lyfgenia for sickle cell disease ...